期刊文献+

B-myb在人肝细胞癌中的表达及其临床意义

Expression and Clinical Significance of B-myb in Hepatocellular Carcinoma
下载PDF
导出
摘要 目的:探讨B-myb的mRNA在人肝细胞癌(hepatocellularcarcinoma,HCC)组织中的表达及其意义。方法:用荧光实时定量聚合酶链反应(RealtimePCR)技术检测70例HCC患者癌组织、癌旁肝组织及18例正常肝组织中B-mybmRNA的表达情况。结果:B-mybmRNA在HCC组织(0·0375±0·0168)及癌旁肝组织(0·0353±0·0128)中的表达水平明显高于在正常肝组织(0·0265±0·0099)中的表达水平,P<0·05,而在HCC组织及癌旁肝组织中的表达水平差异无统计学意义,P>0·05。B-myb在人HCC组织中的表达与临床分期、肝外转移及术后复发明显有关,而与门静脉癌栓、肿瘤个数、肿瘤直径、血清AFP水平及分化程度无明显关系。结论:B-myb可能与HCC的发生、发展有关。 OBJECTIVE:To explore the expression and significance of the B-myb mRNA in human HCC (hepatocellular carcinoma) tissues. METHODS: Real time polymerase chain reaction (Real time PCR) was employed to determine the expression of B-myb mRNA in 70 HCC tissues and their adjacent liver tissues and 18 normal liver tissues. RESULTS: The expression level of B-myb mRNA in the HCC tissue (0. 037 5±0. 016 8) and the adjacent liver tissue (0. 035 3±0. 012 8) was markedly higher than in the normal liver tissues (0.026 5± 0. 009 9, P〈0. 05). The expression level of B-myb mRNA were not significantly different in the HCC tissue than in the adjacent liver tissue (P〉0.05). The expression of B-myb in the HCC tissue was significantly correlated with the clinical stage, the presence of extrahepatic metastasis, and the recurrence of tumor, but not correlated with the Portal Vein Tumor Thrombus, the number of tumor, the diameter of tumor, the level of serum alph-fetoprotein (AFP), and the differentiation of tumor. CONCLUSIONS: The results suggest that B-myb may be related to the initiation and progression of HCC.
出处 《中华肿瘤防治杂志》 CAS 2006年第20期1575-1577,1590,共4页 Chinese Journal of Cancer Prevention and Treatment
基金 广西青年科学基金(桂科青0447050) 广西留学回国人员科技活动择优资助项目(桂人函[2005]321号)
关键词 癌基因 基因表达 肝细胞 聚合酶链反应 oncgenes gene expression carcinoma hepatocellular polymerase chain reaction
  • 相关文献

参考文献10

  • 1陈汝福,邹声泉.肝细胞癌根治性切除术后复发与转移的研究进展[J].肿瘤防治杂志,2000,7(1):83-85. 被引量:8
  • 2Saville M K,Watson R J.B-myb:a key regulator of the cell cycle[J].Adv Cancer Res,1998,72:109-140.
  • 3Hibi K,Liu Q,Beaudry G A,et al.Serial analysis of gene expression in non-small cell lung cancer[J].Cancer Res,1998,58(24):5690-5694.
  • 4Raschella G,Cesi V,Amendola R,et al.Expression of B-myb in Neuroblastoma Tumors Is a Poor Prognostic Factor Independent from MYCN Amplification[J].Cancer Res,1999,59 (14):3365-3368.
  • 5Amatschek S,Koenig U,Auer H,et al.Tissue-wide expression profiling using cDNA subtraction and microarrays to identify tumor-specific genes[J].Cancer Res,2004,64(3):844-856.
  • 6李瑗,苏建家,曹骥,欧超,仇效坤,班克臣,杨春,覃柳亮,罗丹,岳惠芬,张丽生,万大方,顾健人.用cDNA阵列技术研究黄曲霉毒素B1诱发树鼩肝癌形成过程中的基因变化[J].中华肝脏病杂志,2003,11(2):96-99. 被引量:10
  • 7Fu M,Wang C,Li Z,et al.Minireview:Cyclin D1:normal and abnormal functions[J].Endocrinology,2004,145 (12):5439 -5447.
  • 8Joaquin M,Watson R J.The Cell Cycle-regulated B-myb Transcription Factor Overcomes Cyclin-dependent Kinase Inhibitory Activity of p57KIP2 by Interacting with Its Cyclin-binding Domain[J].J Biol Chem,2003,278(45):44255-44264.
  • 9Sala A.B-MYB,a transcription factor implicated in regulating cell cycle,apoptosis and cancer[J].Eur J Cancer,2005,41 (16):2479-2484.
  • 10Brignole C,Marimpietri D,Pagnan G,et al.Neuroblastoma targeting by c-myb-selective antisense oligonucleotides entrapped in anti-GD2 immunoliposome:immune cell-mediated anti-tumor activities[J].Cancer Lett,2005,228(1-2):181-186.

二级参考文献14

  • 1陈汝福,邹声泉.肝门部胆管癌的分子生物学研究新进展[J].中华肝胆外科杂志,1998,4(2):127-127. 被引量:4
  • 2 Boix L,Bruix J,Campo E.nm23-H1 expession and disease recurrence after surgicalresection of small hepatocellular carcinoma[J].Gastroenterology,1994,107(2):486-489.
  • 3 Taketomi A,Takenaka K,Matsumata T,et al.Circulating intercellular adhesionmolecule-1 in patients with hepatocellular carcinoma before and after hepatic resection[J].Hepotogastroenterology,1997,44(14):477-480.
  • 4 Yamamoto H,Itoh F,Sakamoto H,et al.Association of reduce cell adhesion regulatormessenger RNA expression with tumor progression in human hepatocellular carcinoma[J].Gastroenterology,1997,74(3):251-254.
  • 5 Morita Y,Hayashi Y,Wang Y,et al.Expression of urokinase-type plasminogenactivator receptor in hepatocellular carcinoma[J].Hepatology,1997,25(4):856-858.
  • 6 Kumada T,Nakano S,Takede I,et al.Patterns of after initial treatment in patientswith small hepatocellular carcinoma[J].Hepatology,1997,25(1):87-89.
  • 7 Adachi E,Maeda T,Matsumata T,et al.Risk factors for intrahepatic recurrence inhuman small hepatocellular carcinoma[J].Gastroenterology,1995,108(3):768-770.
  • 8 Louha M,Poussin K,Ganne N,et al.Spontanous and iatrogenic spreading ofliver-deriived cells into peripheral blood of patients with primary liver cancer[J].Hepatology,1997,26(4):998-999.
  • 9 Jin-no K,Tanimizu M,Hyodo I,et al.Circulating vascular endothelial growthfactor is a possible tumor marker for metastasis in human hetatocellular carcinoma[J].JGastroentenol,1998,33(2):376-381.
  • 10陈汝福.抗肿瘤血管形成基因治疗研究现状[J].国外医学(肿瘤学分册),1998,25(4):211-212. 被引量:13

共引文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部